Ken Griffin Wave Life Sciences Ltd. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 69,200 shares of WVE stock, worth $784,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,200

Previous 10,400 565.38%

Holding current value

$784,036

Previous $85,000 907.06%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$8.0 - $16.44 $7.47 Million - $15.4 Million	-934,368 Reduced 99.66%	3,218 $39,000
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $4.67 Million - $8.22 Million	912,870 Added 3693.44%	937,586 $7.69 Million
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $262,418 - $388,236	-59,913 Reduced 70.79%	24,716 $123,000
Q1 2024 May 15, 2024	SELL	$3.54 - $6.84 $6.72 Million - $13 Million	-1,897,623 Reduced 95.73%	84,629 $522,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $8.25 Million - $13.6 Million	1,982,252 New	1,982,252 $10 Million
Q2 2023 Aug 14, 2023	SELL	$3.51 - $4.69 $285,864 - $381,967	-81,443 Reduced 96.32%	3,110 $11,000
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $50,066 - $88,105	-13,985 Reduced 14.19%	84,553 $366,000
Q4 2022 Feb 14, 2023	BUY	$3.18 - $7.0 $313,350 - $689,766	98,538 New	98,538 $689,000
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $12,134 - $19,899	6,067 Added 39.81%	21,305 $43,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $110,559 - $181,331	-35,210 Reduced 69.79%	15,238 $47,000
Q3 2021 Nov 15, 2021	BUY	$4.89 - $7.12 $155,648 - $226,629	31,830 Added 170.96%	50,448 $247,000
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $160,064 - $342,669	-28,532 Reduced 60.51%	18,618 $104,000
Q4 2020 Feb 16, 2021	SELL	$6.99 - $9.26 $4.27 Million - $5.66 Million	-611,441 Reduced 92.84%	47,150 $371,000
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $5.37 Million - $12.4 Million	632,467 Added 2421.02%	658,591 $5.59 Million
Q1 2020 May 15, 2020	SELL	$6.94 - $14.22 $237,903 - $487,461	-34,280 Reduced 56.75%	26,124 $245,000
Q4 2019 Feb 14, 2020	SELL	$7.99 - $37.6 $110,565 - $520,308	-13,838 Reduced 18.64%	60,404 $484,000
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $328,228 - $469,142	17,122 Added 29.98%	74,242 $1.52 Million
Q2 2019 Aug 14, 2019	SELL	$22.93 - $42.84 $526,335 - $983,349	-22,954 Reduced 28.67%	57,120 $1.49 Million
Q1 2019 May 15, 2019	SELL	$32.69 - $47.91 $4.79 Million - $7.02 Million	-146,525 Reduced 64.66%	80,074 $0
Q4 2018 Feb 14, 2019	BUY	$37.1 - $50.11 $7.99 Million - $10.8 Million	215,395 Added 1922.48%	226,599 $9.53 Million
Q1 2018 May 11, 2018	BUY	$32.45 - $54.7 $363,569 - $612,858	11,204 New	11,204 $449,000

Others Institutions Holding WVE

# of Institutions

191

Shares Held

122M

Call Options Held

430K

Put Options Held

330K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $984M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account